Open Access

State of the Art in the treatment of hypertrophic cardiomyopathy

Congress Session

About the speaker

Professor Iacopo Olivotto

Careggi University Hospital (AOUC), Florence (Italy)
11 presentations
5 followers

4 more presentations in this session

Earlier surgical myectomy vs. waiting for a Class I indication is associated with improved long-term survival in symptomatic hypertrophic obstructive cardiomyopathy patients

Speaker: Doctor M. Desai (Cleveland, US)

Thumbnail

A novel risk prediction model for sudden cardiac death in childhood hypertrophic cardiomyopathy (HCM Risk-Kids)

Speaker: Doctor G. Norrish (London, GB)

Thumbnail

Long-term safety and effectiveness of mavacamten in symptomatic obstructive hypertrophic cardiomyopathy (oHCM) patients (pts): update from PIONEER open-label extension (PIONEER-OLE) study

Speaker: Professor A. Wang (Durham, US)

Thumbnail

Short- and long-term outcomes of alcohol septal ablation for hypertrophic obstructive cardiomyopathy in patients with mild left ventricular hypertrophy: a propensity score matching analysis.

Speaker: Professor J. Veselka (Prague, CZ)

Thumbnail

Access the full session

Novel therapeutic targets in hypertrophic cardiomyopathy

Speakers: Professor I. Olivotto, Doctor M. Desai, Doctor G. Norrish, Professor A. Wang, Professor J. Veselka
Thumbnail

About the event

Image

ESC CONGRESS 2019

31 August - 4 September 2019

Sessions Presentations

Related content

Open Access

Intraventricular mass and multivalvular disease: causal agent or silent bystander?

9 December 2021

Open Access

The HEP-COVID Trial

27 August 2021

This platform is supported by

logo Novo Nordisk